Aakash Desai: All set to showcase exciting NSCLC and lung cancer research at ASCO Lung24

Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn:      .

” T-1 ASCO24

All set to showcase exciting NSCLC and lung cancer research!

Current updated management algorithm for NSCLC, with the addition of

1. Periop Pembrolizumab
2. Adjuvant Alectinib
3. Osi/Chemo for EGFRm
4. Ami/Chemo for EGFR Ex20ins
5. Repotrectenib ROS1

All in <1 year! what else did we miss?

And some interesting studies being presented in each setting at ASCO24, with the LAURA in plenary- will it change SOC??”

Source: Aakash Desai/LinkedIn